Impact of time to treatment of oseltamivir on influenza hospitalization cost among Korean children

Jacqueline K. Lim, Paul E. Kilgore, Allison E. Aiello, Betsy Foxman, G. William Letson, Giyoung Jang, Eunhee Chung, Young Hwan Song, Yun Kyung Kim

Research output: Contribution to journalArticle

Abstract

Background: Although oseltamivir is a common influenza treatment, there is a lack of data on the economic benefits of timely oseltamivir treatment. Methods: From February 2004 through June 2007, 116 hospitalized children ≤15 years of age with laboratory-confirmed influenza who received oseltamivir were identified via retrospective medical chart review. Demographic, clinical, and cost data were abstracted and multivariate linear regression was used to assess the association between oseltamivir time to treatment and treatment-related costs among hospitalized children with laboratory-confirmed influenza. Results: Overall, 28% (n = 33) of patients were treated with oseltamivir ≥day 3 of admission. Rapid influenza diagnostic test was used in a significantly lower proportion of patients treated with oseltamivir ≥day 3 of admission compared with those who received oseltamivir earlier. On multivariate linear regression, initiation of oseltamivir ≥day 3 of admission was associated with a 60.84% increase (95%CI: 32.59-95.11) in treatment-related hospital costs, compared with initiation on admission. Conclusion: Delayed initiation of oseltamivir was found to be associated with increased treatment-related hospital costs among children hospitalized with laboratory-confirmed influenza.

Original languageEnglish
Pages (from-to)393-400
Number of pages8
JournalPediatrics International
Volume57
Issue number3
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Oseltamivir
Human Influenza
Hospitalization
Costs and Cost Analysis
Hospitalized Child
Therapeutics
Hospital Costs
Linear Models
Routine Diagnostic Tests
Health Care Costs
Economics
Demography

Keywords

  • children
  • hospital cost
  • influenza
  • oseltamivir
  • rapid influenza diagnostic test

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Impact of time to treatment of oseltamivir on influenza hospitalization cost among Korean children. / Lim, Jacqueline K.; Kilgore, Paul E.; Aiello, Allison E.; Foxman, Betsy; Letson, G. William; Jang, Giyoung; Chung, Eunhee; Song, Young Hwan; Kim, Yun Kyung.

In: Pediatrics International, Vol. 57, No. 3, 01.01.2015, p. 393-400.

Research output: Contribution to journalArticle

Lim, JK, Kilgore, PE, Aiello, AE, Foxman, B, Letson, GW, Jang, G, Chung, E, Song, YH & Kim, YK 2015, 'Impact of time to treatment of oseltamivir on influenza hospitalization cost among Korean children', Pediatrics International, vol. 57, no. 3, pp. 393-400. https://doi.org/10.1111/ped.12526
Lim, Jacqueline K. ; Kilgore, Paul E. ; Aiello, Allison E. ; Foxman, Betsy ; Letson, G. William ; Jang, Giyoung ; Chung, Eunhee ; Song, Young Hwan ; Kim, Yun Kyung. / Impact of time to treatment of oseltamivir on influenza hospitalization cost among Korean children. In: Pediatrics International. 2015 ; Vol. 57, No. 3. pp. 393-400.
@article{a9aebc099f5c4cb8ae250f5e85e07927,
title = "Impact of time to treatment of oseltamivir on influenza hospitalization cost among Korean children",
abstract = "Background: Although oseltamivir is a common influenza treatment, there is a lack of data on the economic benefits of timely oseltamivir treatment. Methods: From February 2004 through June 2007, 116 hospitalized children ≤15 years of age with laboratory-confirmed influenza who received oseltamivir were identified via retrospective medical chart review. Demographic, clinical, and cost data were abstracted and multivariate linear regression was used to assess the association between oseltamivir time to treatment and treatment-related costs among hospitalized children with laboratory-confirmed influenza. Results: Overall, 28{\%} (n = 33) of patients were treated with oseltamivir ≥day 3 of admission. Rapid influenza diagnostic test was used in a significantly lower proportion of patients treated with oseltamivir ≥day 3 of admission compared with those who received oseltamivir earlier. On multivariate linear regression, initiation of oseltamivir ≥day 3 of admission was associated with a 60.84{\%} increase (95{\%}CI: 32.59-95.11) in treatment-related hospital costs, compared with initiation on admission. Conclusion: Delayed initiation of oseltamivir was found to be associated with increased treatment-related hospital costs among children hospitalized with laboratory-confirmed influenza.",
keywords = "children, hospital cost, influenza, oseltamivir, rapid influenza diagnostic test",
author = "Lim, {Jacqueline K.} and Kilgore, {Paul E.} and Aiello, {Allison E.} and Betsy Foxman and Letson, {G. William} and Giyoung Jang and Eunhee Chung and Song, {Young Hwan} and Kim, {Yun Kyung}",
year = "2015",
month = "1",
day = "1",
doi = "10.1111/ped.12526",
language = "English",
volume = "57",
pages = "393--400",
journal = "Pediatrics International",
issn = "1328-8067",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Impact of time to treatment of oseltamivir on influenza hospitalization cost among Korean children

AU - Lim, Jacqueline K.

AU - Kilgore, Paul E.

AU - Aiello, Allison E.

AU - Foxman, Betsy

AU - Letson, G. William

AU - Jang, Giyoung

AU - Chung, Eunhee

AU - Song, Young Hwan

AU - Kim, Yun Kyung

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background: Although oseltamivir is a common influenza treatment, there is a lack of data on the economic benefits of timely oseltamivir treatment. Methods: From February 2004 through June 2007, 116 hospitalized children ≤15 years of age with laboratory-confirmed influenza who received oseltamivir were identified via retrospective medical chart review. Demographic, clinical, and cost data were abstracted and multivariate linear regression was used to assess the association between oseltamivir time to treatment and treatment-related costs among hospitalized children with laboratory-confirmed influenza. Results: Overall, 28% (n = 33) of patients were treated with oseltamivir ≥day 3 of admission. Rapid influenza diagnostic test was used in a significantly lower proportion of patients treated with oseltamivir ≥day 3 of admission compared with those who received oseltamivir earlier. On multivariate linear regression, initiation of oseltamivir ≥day 3 of admission was associated with a 60.84% increase (95%CI: 32.59-95.11) in treatment-related hospital costs, compared with initiation on admission. Conclusion: Delayed initiation of oseltamivir was found to be associated with increased treatment-related hospital costs among children hospitalized with laboratory-confirmed influenza.

AB - Background: Although oseltamivir is a common influenza treatment, there is a lack of data on the economic benefits of timely oseltamivir treatment. Methods: From February 2004 through June 2007, 116 hospitalized children ≤15 years of age with laboratory-confirmed influenza who received oseltamivir were identified via retrospective medical chart review. Demographic, clinical, and cost data were abstracted and multivariate linear regression was used to assess the association between oseltamivir time to treatment and treatment-related costs among hospitalized children with laboratory-confirmed influenza. Results: Overall, 28% (n = 33) of patients were treated with oseltamivir ≥day 3 of admission. Rapid influenza diagnostic test was used in a significantly lower proportion of patients treated with oseltamivir ≥day 3 of admission compared with those who received oseltamivir earlier. On multivariate linear regression, initiation of oseltamivir ≥day 3 of admission was associated with a 60.84% increase (95%CI: 32.59-95.11) in treatment-related hospital costs, compared with initiation on admission. Conclusion: Delayed initiation of oseltamivir was found to be associated with increased treatment-related hospital costs among children hospitalized with laboratory-confirmed influenza.

KW - children

KW - hospital cost

KW - influenza

KW - oseltamivir

KW - rapid influenza diagnostic test

UR - http://www.scopus.com/inward/record.url?scp=84933671856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933671856&partnerID=8YFLogxK

U2 - 10.1111/ped.12526

DO - 10.1111/ped.12526

M3 - Article

VL - 57

SP - 393

EP - 400

JO - Pediatrics International

JF - Pediatrics International

SN - 1328-8067

IS - 3

ER -